CEO to participate in H.C. Wainwright Global Investment Conference fireside chat

What did CYBIN INC. announce?

Helus Pharma CEO Michael Halstead will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference.

Key details

• The fireside chat is scheduled for Monday, September 14, 2026, at 9:00 a.m. EDT.
• A live webcast will be available, with a replay on the investor relations website.
• Helus Pharma is a clinical-stage pharmaceutical company developing novel serotonergic agonists.

Why it matters

This 6-K reports a corporate disclosure at CYBIN INC.. The likely share-price reaction reads as neutral.

More from CYBIN INC.

• 4

  Sep 11, 2026
  Chief Growth Officer buys $1.25M of common shares
• 4

  Sep 11, 2026
  Chief Growth Officer buys $1.25M of stock
• 4

  Sep 11, 2026
  Executive Chair buys $1.24M of common shares
• 6-K

  Sep 10, 2026
  CEO to participate in Morgan Stanley Healthcare Conference fireside chat
• 4

  Sep 10, 2026
  Executive Chair buys $1.2M of stock

All CYBIN INC. SEC filings →